In light of the recent concern over a potential link between antidepressants
and suicide in children and adolescents, the Food and Drug Administration
(FDA) will now conduct a study on the risks to adults.
The FDA previously found no increased risk of suicide in adults but
will now reexamine existing data on adult clinical trials in the same detailed
fashion it used for analysis in the young. On October 15, the FDA said it
was ordering manufacturers to add a “black box” warning to the
packaging information of all antidepressants about the potential risk of increased
suicidal tendencies in children and adolescents.
Hampton T. Antidepressant Risks for Adults. JAMA. 2004;292(20):2457. doi:10.1001/jama.292.20.2457-c